AutoComBat: a generic method for harmonizing MRI-based radiomic features.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
26 07 2022
Historique:
received: 25 11 2021
accepted: 12 07 2022
entrez: 26 7 2022
pubmed: 27 7 2022
medline: 29 7 2022
Statut: epublish

Résumé

The use of multicentric data is becoming essential for developing generalizable radiomic signatures. In particular, Magnetic Resonance Imaging (MRI) data used in brain oncology are often heterogeneous in terms of scanners and acquisitions, which significantly impact quantitative radiomic features. Various methods have been proposed to decrease dependency, including methods acting directly on MR images, i.e., based on the application of several preprocessing steps before feature extraction or the ComBat method, which harmonizes radiomic features themselves. The ComBat method used for radiomics may be misleading and presents some limitations, such as the need to know the labels associated with the "batch effect". In addition, a statistically representative sample is required and the applicability of a signature whose batch label is not present in the train set is not possible. This work aimed to compare a priori and a posteriori radiomic harmonization methods and propose a code adaptation to be machine learning compatible. Furthermore, we have developed AutoComBat, which aims to automatically determine the batch labels, using either MRI metadata or quality metrics as inputs of the proposed constrained clustering. A heterogeneous dataset consisting of high and low-grade gliomas coming from eight different centers was considered. The different methods were compared based on their ability to decrease relative standard deviation of radiomic features extracted from white matter and on their performance on a classification task using different machine learning models. ComBat and AutoComBat using image-derived quality metrics as inputs for batch assignment and preprocessing methods presented promising results on white matter harmonization, but with no clear consensus for all MR images. Preprocessing showed the best results on the T1w-gd images for the grading task. For T2w-flair, AutoComBat, using either metadata plus quality metrics or metadata alone as inputs, performs better than the conventional ComBat, highlighting its potential for data harmonization. Our results are MRI weighting, feature class and task dependent and require further investigations on other datasets.

Identifiants

pubmed: 35882891
doi: 10.1038/s41598-022-16609-1
pii: 10.1038/s41598-022-16609-1
pmc: PMC9325761
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

12762

Informations de copyright

© 2022. The Author(s).

Références

J Neural Eng. 2020 Apr 30;17(2):021002
pubmed: 32191935
Neuroinformatics. 2011 Dec;9(4):381-400
pubmed: 21373993
Radiographics. 2006 Jan-Feb;26(1):275-97
pubmed: 16418258
Sci Data. 2017 Sep 05;4:170117
pubmed: 28872634
Sci Rep. 2020 Jul 23;10(1):12340
pubmed: 32704007
Eur J Cancer. 2012 Mar;48(4):441-6
pubmed: 22257792
Neuroimage Clin. 2014 Aug 15;6:9-19
pubmed: 25379412
AJR Am J Roentgenol. 2019 Jan;212(1):26-37
pubmed: 30332296
Hum Brain Mapp. 2010 May;31(5):798-819
pubmed: 20017133
AJNR Am J Neuroradiol. 2002 Sep;23(8):1327-33
pubmed: 12223373
J Digit Imaging. 2013 Dec;26(6):1045-57
pubmed: 23884657
Neuro Oncol. 2015 Sep;17(9):1188-98
pubmed: 26250565
Methods. 2021 Apr;188:112-121
pubmed: 32522530
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Invest Radiol. 2009 Jul;44(7):405-11
pubmed: 19465863
Magn Reson Med. 1997 Sep;38(3):429-39
pubmed: 9339445
Med Phys. 2020 Dec;47(12):6029-6038
pubmed: 33176026
Neuroimage. 2018 Feb 15;167:104-120
pubmed: 29155184
BMC Bioinformatics. 2015 Feb 25;16:63
pubmed: 25887219
World Neurosurg. 2019 Dec;132:e140-e161
pubmed: 31505292
Magn Reson Imaging Clin N Am. 2016 Nov;24(4):719-729
pubmed: 27742112
RMD Open. 2018 Jun 20;4(1):e000728
pubmed: 29955387
Neuroimage. 2017 Nov 1;161:149-170
pubmed: 28826946
Theranostics. 2019 Feb 12;9(5):1303-1322
pubmed: 30867832
Med Phys. 2009 Apr;36(4):1236-43
pubmed: 19472631
Med Phys. 2019 Jan;46(1):180-189
pubmed: 30352129
PLoS One. 2017 Jun 6;12(6):e0178843
pubmed: 28586353
Magn Reson Med. 1999 Dec;42(6):1072-81
pubmed: 10571928
Magn Reson Med. 1996 Sep;36(3):494-7
pubmed: 8875425
AJNR Am J Neuroradiol. 2017 Aug;38(8):1501-1509
pubmed: 28642263
Phys Med Biol. 2016 Jul 7;61(13):R150-66
pubmed: 27269645
Korean J Radiol. 2020 Oct;21(10):1126-1137
pubmed: 32729271
Hum Brain Mapp. 2019 Dec 1;40(17):4952-4964
pubmed: 31403237
Cancer Res. 2017 Nov 1;77(21):e104-e107
pubmed: 29092951
IEEE Trans Med Imaging. 2010 Jun;29(6):1310-20
pubmed: 20378467
J Neuroradiol. 2015 Jul;42(4):212-21
pubmed: 24997477
J Magn Reson Imaging. 2010 Nov;32(5):1197-208
pubmed: 21031526
PLoS One. 2017 Sep 25;12(9):e0184661
pubmed: 28945803
Nat Commun. 2014 Jun 03;5:4006
pubmed: 24892406
Sci Rep. 2020 Jun 24;10(1):10248
pubmed: 32581221
Front Oncol. 2021 Jan 20;10:541663
pubmed: 33552944
Neuro Oncol. 2018 May 18;20(6):848-857
pubmed: 29036412
Ann Oncol. 2017 Jun 1;28(6):1191-1206
pubmed: 28168275
Magn Reson Imaging. 2019 Dec;64:160-170
pubmed: 31301354
Neuroimage. 2020 Oct 15;220:117127
pubmed: 32634595
J Magn Reson Imaging. 2005 Nov;22(5):674-80
pubmed: 16215966
Med Phys. 2013 Jul;40(7):
pubmed: 28524933
J Magn Reson Imaging. 2015 Oct;42(4):887-901
pubmed: 25630632
PLoS One. 2019 Mar 7;14(3):e0213459
pubmed: 30845221
Phys Med Biol. 2020 Dec 17;65(24):24TR02
pubmed: 32688357
PLoS One. 2015 May 28;10(5):e0127855
pubmed: 26020531
Eur Radiol. 2021 Apr;31(4):2272-2280
pubmed: 32975661
Sci Rep. 2020 Feb 28;10(1):3711
pubmed: 32111869

Auteurs

Alexandre Carré (A)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France.
Institut Gustave Roussy, Département de Radiothérapie, 94800, Villejuif, France.

Enzo Battistella (E)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France.
Université Paris-Saclay, CentraleSupélec, Mathématiques et Informatique pour la Complexité et les Systèmes, 91190, Gif-sur-Yvette, France.
Université Paris-Saclay, CentraleSupélec, Inria, Gif-sur-Yvette, France.

Stephane Niyoteka (S)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France.
Institut Gustave Roussy, Département de Radiothérapie, 94800, Villejuif, France.

Roger Sun (R)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France.
Institut Gustave Roussy, Département de Radiothérapie, 94800, Villejuif, France.

Eric Deutsch (E)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France.
Institut Gustave Roussy, Département de Radiothérapie, 94800, Villejuif, France.

Charlotte Robert (C)

Université Paris-Saclay, Institut Gustave Roussy, Inserm, Radiothérapie Moléculaire et Innovation Thérapeutique, 94800, Villejuif, France. ch.ROBERT@gustaveroussy.fr.
Institut Gustave Roussy, Département de Radiothérapie, 94800, Villejuif, France. ch.ROBERT@gustaveroussy.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH